Results 151 to 160 of about 411,709 (279)

Patent portfolios and Patent Assertion Entities: antitrust issues and future perspective under the Unified Patent Court

open access: yesRevista de Estudios Jurídicos y Criminológicos
Protecting research has always been a relevant issue in order to foster innovation, especially in the pharmaceutical field. Intellectual property rights protection plays a main role in the current economy since it allows companies to monetize efforts ...
Pietro Cappabianca
doaj  

Taxation, R&D tax incentives and patent application in Europe [PDF]

open access: yes
The focus of this paper is on effects from tax incentives for research and development inputs (R&D) and corporate income tax on business R&D and patenting behaviour.
Ernst, Christof, Spengel, Christoph
core  

Multidimensional Profiling of MRI‐Negative Temporal Lobe Epilepsy Uncovers Distinct Phenotypes

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Although hippocampal sclerosis (TLE‐HS) represents the most frequent cause of temporal lobe epilepsy (TLE), up to 30% of patients show no lesion on visual MRI inspection (TLE‐MRIneg). These cases pose diagnostic and therapeutic challenges and are underrepresented in surgical series.
Alice Ballerini   +28 more
wiley   +1 more source

Policy barriers to drug repurposing in Europe: different stakeholder perspectives identified during survey-based shortlisting of key challenges. [PDF]

open access: yesHealth Policy Open
Gyöngyösi K   +9 more
europepmc   +1 more source

Low Incidence of Relapses After Vaccination in Anti‐Aquaporin‐4 Antibody‐Positive NMOSD

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Patients with neuromyelitis optica spectrum disorder (NMOSD) may experience increased signs and symptoms of their underlying disease when vaccinated against meningococcal disease before receiving complement component 5 inhibitor therapies. This retrospective analysis indicated an overall low relapse incidence (mean [range], 3.3% [0.7%–10.6 ...
Sean J. Pittock   +4 more
wiley   +1 more source

Price transparency of cancer medicines: a crucial step towards informed pricing negotiations in the European region. [PDF]

open access: yesFront Pharmacol
Vancoppenolle J   +14 more
europepmc   +1 more source

Everything you Always Wanted to Know About Inventors (But Never Asked): Evidence from the PatVal-EU Survey [PDF]

open access: yes
Based on a survey of the inventors of 9,017 European patented inventions, this paper provides new information about the characteristics of European inventors, the sources of their knowledge, the importance of formal and informal collaborations, the ...
Harhoff, Dietmar, Hoisl, Karin
core  

Sex Representation in US Stroke Clinical Trials: A Decade of Trends and Challenges

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Stroke remains a major cause of disability and mortality in the US, with significant sex‐based disparities, and females remain underrepresented in stroke clinical trials. We aimed to examine sex representation in US‐based stroke clinical trials, identify trial characteristics associated with higher female enrollment (≥ 50%), and ...
Chaitali Dagli   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy